<VariationArchive VariationID="1431756" VariationName="NM_000540.3(RYR1):c.4674dup (p.Asn1559fs)" VariationType="Duplication" Accession="VCV001431756" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1405827" VariationID="1431756">
      <GeneList>
        <Gene Symbol="RYR1" FullName="ryanodine receptor 1" GeneID="6261" HGNC_ID="HGNC:10483" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38433691" stop="38587564" display_start="38433691" display_stop="38587564" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38924339" stop="39078203" display_start="38924339" display_stop="39078203" Strand="+" />
          </Location>
          <OMIM>180901</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000540.3(RYR1):c.4674dup (p.Asn1559fs)</Name>
      <CanonicalSPDI>NC_000019.10:38483079:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38483079" stop="38483080" display_start="38483079" display_stop="38483080" variantLength="1" positionVCF="38483079" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38973719" stop="38973720" display_start="38973719" display_stop="38973720" variantLength="1" positionVCF="38973719" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>N1559fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.38483080dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.38483080dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.38973720dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.38973720dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008866.1" sequenceAccession="NG_008866" sequenceVersion="1" change="g.54381dup">
            <Expression>NG_008866.1:g.54381dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000540.3" sequenceAccession="NM_000540" sequenceVersion="3" change="c.4674dup" MANESelect="true">
            <Expression>NM_000540.3:c.4674dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000531.2" sequenceAccession="NP_000531" sequenceVersion="2" change="p.Asn1559fs">
            <Expression>NP_000531.2:p.Asn1559fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042723.2" sequenceAccession="NM_001042723" sequenceVersion="2" change="c.4674dup">
            <Expression>NM_001042723.2:c.4674dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001036188.1" sequenceAccession="NP_001036188" sequenceVersion="1" change="p.Asn1559fs">
            <Expression>NP_001036188.1:p.Asn1559fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_766" sequenceAccession="LRG_766">
            <Expression>LRG_766:g.54381dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="759632485" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000540.3(RYR1):c.4674dup (p.Asn1559fs) AND RYR1-related disorder" Accession="RCV001967613" Version="3">
        <ClassifiedConditionList TraitSetID="33623">
          <ClassifiedCondition DB="MedGen" ID="CN239331">RYR1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.4674dup (p.Asn1559fs) AND multiple conditions" Accession="RCV002484631" Version="1">
        <ClassifiedConditionList TraitSetID="81991">
          <ClassifiedCondition DB="MedGen" ID="C0751951">Central core myopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1850674">Congenital multicore myopathy with external ophthalmoplegia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0546264">Congenital myopathy with fiber type disproportion</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1840365">King Denborough syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2930980">Malignant hyperthermia, susceptibility to, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23919265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25960145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28818389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30611313</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33623" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36528" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RYR1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">RYR1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RYR1-related condition</ElementValue>
              </Name>
              <XRef ID="CN239331" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81991" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="865" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Central core disease</ElementValue>
                <XRef ID="Central+Core+Disease/1190" DB="Genetic Alliance" />
                <XRef ID="43152001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Central core disease of muscle</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle core disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular central core disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathy, central fibrillar</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Shy-Magee syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Central core myopathy</ElementValue>
                <XRef ID="MONDO:0007294" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1A</ElementValue>
                <XRef Type="MIM" ID="117000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CCO</ElementValue>
                <XRef Type="MIM" ID="117000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6014" />
                <XRef ID="6014" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21989361</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="597" DB="Orphanet" />
              <XRef ID="C0751951" DB="MedGen" />
              <XRef ID="MONDO:0007294" DB="MONDO" />
              <XRef Type="MIM" ID="117000" DB="OMIM" />
            </Trait>
            <Trait ID="2639" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malignant hyperthermia, susceptibility to, 1</ElementValue>
                <XRef ID="MONDO:0007783" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperthermia suceptibility 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anesthesia related hyperthermia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fulminating hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharmacogenic myopathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MHS1</ElementValue>
                <XRef Type="MIM" ID="145600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeletal muscle hypermetabolism. Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile anesthetics (i.e., halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in conjunction with a depolarizing muscle relaxant (specifically, succinylcholine). The triggering substances cause uncontrolled release of calcium from the sarcoplasmic reticulum and may promote entry of extracellular calcium into the myoplasm, causing contracture of skeletal muscles, glycogenolysis, and increased cellular metabolism, resulting in production of heat and excess lactate. Affected individuals experience acidosis, hypercapnia, tachycardia, hyperthermia, muscle rigidity, compartment syndrome, rhabdomyolysis with subsequent increase in serum creatine kinase (CK) concentration, hyperkalemia with a risk for cardiac arrhythmia or even cardiac arrest, and myoglobinuria with a risk for renal failure. In nearly all cases, the first manifestations of MH (tachycardia and tachypnea) occur in the operating room; however, MH may also occur in the early postoperative period. There is mounting evidence that some individuals with MHS will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high.</Attribute>
                <XRef ID="NBK1146" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3363" />
                <XRef ID="3363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EMHG, 2018">
                <ID Source="PubMed">33131754</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301325</ID>
                <ID Source="BookShelf">NBK1146</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3110041</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Sei et al., 2004">
                <ID Source="PubMed">14870754</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_MalignantHyperthermia-enPro649.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Malignant hyperthermia</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Malignant-Hyperthermia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, RYR1 and CACNA1S Pathogenic Variants (Malignant Hyperthermia), 2019</CitationText>
              </Citation>
              <XRef ID="423" DB="Orphanet" />
              <XRef ID="C2930980" DB="MedGen" />
              <XRef ID="MONDO:0007783" DB="MONDO" />
              <XRef Type="MIM" ID="145600" DB="OMIM" />
            </Trait>
            <Trait ID="6212" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">King Denborough syndrome</ElementValue>
                <XRef ID="764957003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">King syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KDS</ElementValue>
                <XRef Type="MIM" ID="619542" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8433" />
                <XRef ID="8433" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1840365" DB="MedGen" />
              <XRef ID="MONDO:0020485" DB="MONDO" />
              <XRef Type="MIM" ID="619542" DB="OMIM" />
            </Trait>
            <Trait ID="5593" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myopathy with fiber type disproportion</ElementValue>
                <XRef ID="Congenital+Fiber+Type+Disproportion/1827" DB="Genetic Alliance" />
                <XRef ID="240084007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital fiber-type disproportion myopathy</ElementValue>
                <XRef ID="MONDO:0009711" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital Fiber-Type Disproportion</ElementValue>
                <XRef ID="NBK1259" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CFTDM</ElementValue>
                <XRef Type="MIM" ID="255310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TPM3-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">all</Attribute>
                <XRef ID="GTR000276064" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SELENON-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6161" />
                <XRef ID="6161" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ACTA1-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <XRef ID="2020" DB="Orphanet" />
              <XRef ID="C0546264" DB="MedGen" />
              <XRef ID="MONDO:0009711" DB="MONDO" />
            </Trait>
            <Trait ID="3205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MULTICORE MYOPATHY</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="C150608" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multicore myopathy with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiminicore disease with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital myopathy 1B, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy</ElementValue>
                <XRef ID="HP:0003789" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital multicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="MONDO:0009712" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1B</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RYR1-Related Multiminicore Disease</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10316" />
                <XRef ID="10316" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="598" DB="Orphanet" />
              <XRef ID="98905" DB="Orphanet" />
              <XRef ID="C1850674" DB="MedGen" />
              <XRef ID="MONDO:0009712" DB="MONDO" />
              <XRef Type="MIM" ID="255320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003789" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003804" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5442093" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000540.3:c.4674dup|OMIM:117000;145600;255310;255320;619542" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002786155" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.4674dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="117000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="145600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255310" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255320" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619542" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4229862" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="5206604|MedGen:CN239331" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002214665" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23919265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25960145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28818389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30611313</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn1559Glufs*6) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 23919265, 25960145, 28818389, 30611313). This variant is present in population databases (rs759632485, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1431756). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.38973719_38973720insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239331" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5442093" TraitType="Disease" MappingType="XRef" MappingValue="619542" MappingRef="OMIM">
        <MedGen CUI="C1840365" Name="King Denborough syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5442093" TraitType="Disease" MappingType="XRef" MappingValue="117000" MappingRef="OMIM">
        <MedGen CUI="C0751951" Name="Central core myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4229862" TraitType="Disease" MappingType="XRef" MappingValue="CN239331" MappingRef="MedGen">
        <MedGen CUI="CN239331" Name="RYR1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5442093" TraitType="Disease" MappingType="XRef" MappingValue="145600" MappingRef="OMIM">
        <MedGen CUI="C2930980" Name="Malignant hyperthermia, susceptibility to, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5442093" TraitType="Disease" MappingType="XRef" MappingValue="255310" MappingRef="OMIM">
        <MedGen CUI="CN178536" Name="Congenital myopathy 4A, autosomal dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5442093" TraitType="Disease" MappingType="XRef" MappingValue="255320" MappingRef="OMIM">
        <MedGen CUI="C1850674" Name="Congenital multicore myopathy with external ophthalmoplegia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

